Wellington Biomedical Innovation Master Investors (cayman) I L.p. - Net Worth and Insider Trading

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Aligos Therapeutics Inc (ALGS). Other recent insider transactions involving Aligos Therapeutics Inc (ALGS) include a net purchase of 7,933,601 shares made by Carole Nuechterlein ,

In summary, during the past 3 months, insiders sold 0 shares of Aligos Therapeutics Inc (ALGS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aligos Therapeutics Inc (ALGS) were sold and 317,344 shares were bought by its insiders, resulting in a net purchase of 317,344 shares.

Aligos Therapeutics Inc (ALGS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 11,322 shares made by Deepika Jalota , a net sale of 87,786 shares made by Orbimed Advisors Llc , and a net sale of 6,291 shares made by Leila Alland .

In summary, during the past 3 months, insiders sold 10,109 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 10,109 shares. During the past 18 months, 108,290 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,290 shares.

PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 446,445 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .

In summary, during the past 3 months, insiders sold 1,741,587 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 1,709,587 shares. During the past 18 months, 7,985,414 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,239,129 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .

In summary, during the past 3 months, insiders sold 18,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 18,499 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc (FMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc (FMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Forma Therapeutics Holdings Inc (FMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net purchase of 20,000 shares made by Dannielle Appelhans , a net sale of 9,835 shares made by Antoinette Paone , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,835 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 541,620 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 111,210 shares made by John R Moore , a net sale of 249,161 shares made by Alan J Russell , and a net sale of 217,249 shares made by R Michael Carruthers .

In summary, during the past 3 months, insiders sold 320,244 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 0 shares, with a net sale of 320,244 shares. During the past 18 months, 645,402 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 274,545 shares.

Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 1,802,142 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Nuvalent Inc (NUVL). Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 536,000 shares made by Matthew Shair , a net sale of 143,000 shares made by Darlene Noci , and a net sale of 124,546 shares made by Deborah Ann Miller .

In summary, during the past 3 months, insiders sold 2,146,629 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 2,146,629 shares. During the past 18 months, 3,924,068 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,924,068 shares.

Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Wellington Biomedical Innovation Master Investors (cayman) I L.p. made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net sale of 7,965 shares made by Chione Ltd , and a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd .

In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 2,353,000 shares were bought by its insiders, resulting in a net purchase of 2,345,035 shares.

Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.